life sciences

Welcome to the 'life sciences' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'life sciences'.

Latest blogosphere posts tagged “life sciences”

• Hyper-Analytical “Insanity” Cripples Drug R&D, Says Alnylam CEO John Maraganore

  
  Xconomy — Authority: 702
  Biotech , people , management Luke Timmerman wrote: There’s one thing drug makers love to use to figure out which drugs to invest in: spreadsheets. Not Alnylam Pharmaceuticals, though. Estimates of future cash flows and other financial analysis tools are one of the big reasons why drugmakers spend so ...
  5 hours ago

• Pilot Scheme Launched to Help Patients Receive Innovative New Drugs Not Currently Available on the NHS

  
  Net News Publisher — Authority: 451
  A pilot to help patients get innovative new drugs not currently available on the NHS is being launched for consultation today by Health Minister Mike O’Brien and Science and Innovation Minister Lord Drayson. The Office for Life Sciences (OLS) Blueprint published in July, detailed the Government’s commitment to ...
  1 day ago

• Jonathan Safran Foer – America’s #1 Terrorist?

  
  World Change Cafe — Authority: 120
  By Mikko Alanne With the publication of Jonathan Safran Foer’s captivating and powerful book, Eating Animals, much has been said and written about his undercover investigative work, which gives America a view inside the hidden world of factory farms. What has not been commented on, however, is the disquieting ...
  2 days ago

• New books in the Library – 27th November

  
  spineless? — Authority: 420
  Here’s a selection of new books in Riccarton Library.  Click on the covers below for more details. For the full list of new books, go to the New Books section of the Library Catalogue.                      Information on how to place a reservation for a print book is available.  Information on ...
  2 days ago

• Article Title Unknown

  
  OK4me2 — Authority: 153
  A head start when it comes to eyesight Why do hammerhead sharks have such a famously strange-shaped head? One hypothesis is that having eyes on either side of such a wide hammer allows the sharks to see better. But even this idea divides scientific opinion, as researchers argue over whether the hammerhead ...
  2 days ago

• Evolution of Highly Toxic Box Jellyfish Unraveled

  
  OK4me2 — Authority: 153
  ScienceDaily (Nov. 26, 2009) — With thousands of stinging cells that can emit deadly venom from tentacles that can reach ten feet in length, the 50 or so species of box jellyfish have long been of interest to scientists and to the public. Yet little has been known about the evolution of this early branch in the ...
  3 days ago

• Illumina OKs $100M Share Buyback

  
  Xconomy — Authority: 702
  Biotech , deals , Finances Luke Timmerman wrote: San Diego-based Illumina (NASDAQ: ILMN ) said today that its board has authorized a program to buy back $100 million of stock. The new program is on top of a $75 million share repurchase program the company announced in August. Comments | Reprints | ...
  4 days ago

• Novartis Parts Ways with Idera Pharma

  
  Xconomy — Authority: 702
  Life Sciences , deals , Asthma Ryan McBride wrote: Idera Pharmaceuticals said this morning that it’s losing one of its three key Big Pharma partners. Swiss drug giant Novartis has told Cambridge, MA-based Idera (NASDAQ: IDRA ) that it will terminate their four-year-old collaboration to develop drugs ...
  4 days ago

• Your Commission, Should You Choose to Accept It (And We Do!)

  
  Science Progress — Authority: 462
  Yesterday President Obama issued an Executive Order establishing the Presidential Commission for the Study of Bioethical Issues. The Commission’s Chair will be Amy Gutmann, President of the University of Pennsylvania and a political theorist. Its Vice Chair will be James W. Wagner, President of Emory University and ...
  4 days ago

• Ironwood Pharma Eyes $172.5M IPO, Biogen CEO Pay Under Fire, & More Boston Life Sciences News

  
  Xconomy — Authority: 702
  Life Sciences , deals , Multiple Sclerosis Ryan McBride wrote: Xconomy’s life sciences coverage this past week featured a mix of exclusive feature stories—such as Luke’s analysis of the PML side effect from Biogen Idec’s natalizumab (Tysabri)—and breaking news stories like Ironwood ...
  5 days ago

• Astec Lifesciences Ltd - to list November 25, 2009

  
  Stock Advice — Authority: 138
  Astec Lifesciences Ltd. The equity shares of Astec Lifesciences Limited will be listed and admitted to dealings on the Exchange in the list of B Group effective from Wednesday, November 25, 2009Astec Lifesciences IPO Listing Details:ISIN: INE563J01010IPO Listing Date: Wednesday, November 25, 2009BSE Script Code: ...
  5 days ago

• Genzyme Rival Seeks European Approval

  
  Xconomy — Authority: 702
  Life Sciences , Gaucher disease , Biotech Ryan McBride wrote: Shire (LSE: SHP )—an Ireland-based drug company that has its Human Genetic Therapies unit based in Cambridge, MA— reports that it has asked European regulators to approve its treatment for Gaucher disease, velaglucerase alfa. If approved by ...
  5 days ago

• Quiz: The State of Technology and Life Sciences Executive Compensation

  
  Xconomy — Authority: 702
  X Factor , Executive Pay , startups Robert Buderi wrote: The Boston area is a breeding ground for life sciences and technology innovation. Startups and more established companies are everywhere—and so are the engineers, scientists, CTOs, and operating, finance, and sales whizzes that make these ...
  6 days ago

• Cozi Teams Up with MWV, Naverus Acquired by GE, Bio Architecture Lab Raises $8M, & More Seattle-Area Deals News

  
  Xconomy — Authority: 702
  Roundup , deals , VC Gregory T. Huang wrote: It was a fairly busy week for deals heading into the Thanksgiving holiday. The Northwest saw some action across aviation, alternative fuels, wireless, software, and biotech. —Kent, WA-based Naverus was acquired by GE Aviation , an operating unit of General ...
  6 days ago

• How Millennium Is Tapping A Harvard Lab to Help Discover New Cancer Drugs

  
  Xconomy — Authority: 702
  Life Sciences , cancer , Collaboration Ryan McBride wrote: When Deborah Dunsire, CEO of Millennium: The Takeda Oncology Company, talked about what makes the Boston area an attractive place to do business at a recent Xconomy Forum , she singled out the work of J. Wade Harper at Harvard Medical School. ...
  6 days ago

• In Stem Cell Research, Evidence Trumps Ideology

  
  Science Progress — Authority: 462
  One of the less attractive features of the political debate about human embryonic stem cells has been a tone of triumphalism when one side or the other can register a “victory.” When a Japanese team reported that they had succeeded in deriving cells from skin that have many of the characteristics of cells derived ...
  6 days ago

• EnergyEfficiency Part XII: Making Energy Efficiency Pay

  
  SAP Developer Network SAP Weblogs — Authority: 152
  Energy efficiency is important. In this series of blogs we have been concentrating on what can be done to reduce energy costs and consumption. But there is another side of the equation. Some companies are seeing other oppertunities. In this blog we discuss some of the other ways energy efficiency can pay off.
  6 days ago

• Online Resources Presents Z Corp 3D Printers

  
  | Creo Quality, LLC — Authority: 473
  Online Resources Presents: Speed Ease Versatility Affordability Z Corp’s products include the world’s fastest high-definition 3D printers — machines that produce physical 3D models from digital data in full color. Their products enable a wide range of applications in manufacturing, AEC, civil engineering, ...
  6 days ago

• Orexigen Beefs Up Management

  
  Xconomy — Authority: 702
  Biotech , people , obesity Luke Timmerman wrote: Orexigen Therapeutics (NASDAQ: OREX ), the San Diego-based developer of obesity drugs, said today it has added four new executives to its management team. Dawn Viveash is the new head of global regulatory affairs; Suzanne McDonald will be responsible for ...
  6 days ago

• Seattle Genetics Gets $12M From Agensys

  
  Xconomy — Authority: 702
  Biotech , cancer , deals Luke Timmerman wrote: Seattle Genetics, the Bothell, WA-based developer of cancer drugs, said today it will get a $12 million upfront fee from Agensys, an affiliate of Japan-based Astellas Pharma, under a renegotiated partnership to develop targeted antibody treatments loaded ...
  6 days ago

Comments about life sciences